Home
/
NATURAL ALTERNATIVES INTERNATIONAL INC
/
Financials
/
Quarterly
NATURAL ALTERNATIVES INTERNATIONAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NATURAL ALTERNATIVES INTERNATIONAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2019
Dec 31, 2018
$36.04M
Feb 12, 2019
Q1
2019
Sep 30, 2018
$36.53M
Nov 13, 2018
Q3
2018
Mar 31, 2018
$31.82M
May 14, 2018
Q2
2019
Dec 31, 2017
$33.34M
Feb 12, 2019
Q1
2019
Sep 30, 2017
$28.07M
Nov 13, 2018
Q3
2018
Mar 31, 2017
$25.14M
May 14, 2018
Q3
2015
Mar 31, 2015
$12.68M
May 12, 2015
Q3
2015
Mar 31, 2014
$12.07M
May 12, 2015
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Dec 31, 2017
$33.34M
Feb 13, 2018
Q1
2018
Sep 30, 2017
$28.07M
Nov 13, 2017
Q3
2017
Mar 31, 2017
$25.14M
May 15, 2017
Q2
2018
Dec 31, 2016
$30.56M
Feb 13, 2018
Q1
2018
Sep 30, 2016
$34.07M
Nov 13, 2017
Q3
2017
Mar 31, 2016
$30.01M
May 15, 2017
Q2
2017
Dec 31, 2015
$26.91M
Feb 14, 2017
Q1
2017
Sep 30, 2015
$21.59M
Nov 7, 2016
Q3
2016
Mar 31, 2015
$19.61M
May 10, 2016
Q2
2016
Dec 31, 2014
$18.62M
Feb 9, 2016
Q1
2016
Sep 30, 2014
$18.70M
Nov 12, 2015
Q3
2015
Mar 31, 2014
$19.13M
May 12, 2015
Q2
2015
Dec 31, 2013
$16.48M
Feb 12, 2015
Q1
2015
Sep 30, 2013
$17.16M
Nov 12, 2014
Q3
2014
Mar 31, 2013
$15.84M
May 13, 2014
Q2
2013
Dec 31, 2012
$13.69M
Feb 12, 2013
Q1
2014
Sep 30, 2012
$16.46M
Nov 13, 2013
Q3
2012
Mar 31, 2012
$17.42M
May 14, 2012
Q2
2013
Dec 31, 2011
$16.16M
Feb 12, 2013
Q1
2013
Sep 30, 2011
$18.34M
Nov 14, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 25, 2031
($2.38M)
May 15, 2023
Q2
2026
Dec 31, 2025
($2.55M)
Feb 13, 2026
Q1
2026
Sep 30, 2025
($291.0K)
Nov 12, 2025
Q3
2025
Mar 31, 2025
($2.19M)
May 14, 2025
Q2
2026
Dec 31, 2024
($2.19M)
Feb 13, 2026
Q1
2026
Sep 30, 2024
($1.98M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($1.58M)
May 14, 2025
Q2
2025
Dec 31, 2023
($3.07M)
Feb 14, 2025
Q1
2025
Sep 30, 2023
($695.0K)
Nov 13, 2024
Q3
2024
Mar 31, 2023
($2.38M)
May 14, 2024
Q2
2024
Dec 31, 2022
$1.81M
Feb 13, 2024
Q1
2024
Sep 30, 2022
$1.05M
Nov 9, 2023
Q3
2022
Mar 31, 2022
$2.50M
May 15, 2023
Q2
2022
Dec 31, 2021
$1.85M
Feb 8, 2023
Q1
2022
Sep 30, 2021
$3.26M
Nov 9, 2022
Q3
2022
Mar 31, 2021
$1.92M
May 13, 2022
Q2
2022
Dec 31, 2020
$3.63M
Feb 9, 2022
Q1
2022
Sep 30, 2020
$2.26M
Nov 9, 2021
Q3
2021
Mar 31, 2020
($4.02M)
May 13, 2021
Q2
2021
Dec 31, 2019
$476.0K
Feb 9, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 25, 2031
($2.49M)
May 15, 2023
Q2
2026
Dec 31, 2025
($1.85M)
Feb 13, 2026
Q1
2026
Sep 30, 2025
$284.0K
Nov 12, 2025
Q3
2025
Mar 31, 2025
($2.10M)
May 14, 2025
Q2
2026
Dec 31, 2024
($2.78M)
Feb 13, 2026
Q1
2026
Sep 30, 2024
($1.84M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($1.95M)
May 14, 2025
Q2
2025
Dec 31, 2023
($3.51M)
Feb 14, 2025
Q2
2024
Dec 30, 2023
($3.51M)
Feb 13, 2024
Q1
2025
Sep 30, 2023
($544.0K)
Nov 13, 2024
Q3
2024
Mar 31, 2023
($2.49M)
May 14, 2024
Q2
2024
Dec 31, 2022
$2.49M
Feb 13, 2024
Q2
2024
Dec 30, 2022
$2.49M
Feb 13, 2024
Q1
2024
Sep 30, 2022
$1.54M
Nov 9, 2023
Q3
2022
Mar 31, 2022
$3.27M
May 15, 2023
Q2
2022
Dec 31, 2021
$2.40M
Feb 8, 2023
Q1
2022
Sep 30, 2021
$4.23M
Nov 9, 2022
Q3
2022
Mar 31, 2021
$2.70M
May 13, 2022
Q2
2022
Dec 31, 2020
$5.39M
Feb 9, 2022
Q1
2022
Sep 30, 2020
$2.09M
Nov 9, 2021